IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries.
MOUNTAIN VIEW, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today reported financial results for the third quarter and nine months ended September 30, 2017.
Third Quarter Highlights
Record third quarter revenue of $10.9 million, an 11% year-over-year increase
Shipped 111 Cyclo G6 systems and approximately 7,800 G6 probes
Significantly expanded marketing presence at worldwide industry events:
-- European Society of Cataract and Refractive Surgeons (...
MOUNTAIN VIEW, Calif., Oct. 26, 2017 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today announced the Company plans to participate in two upcoming investor conferences.
November 9, 2017 at 1:30pm ET, IRIDEX’s management is scheduled to present at the Canaccord Genuity Medical Technologies & Diagnostics Forum in New York, NY
November 14, 2017 at 9:30am ET, IRIDEX’s management is scheduled to present at the Stifel 2017 Healthcare Conference in New York, NY
MOUNTAIN VIEW, Calif., Oct. 19, 2017 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today announced the Company will release financial results for the third quarter 2017 after the close of trading on Thursday, November 2, 2017. The Company’s management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET.
Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-3030 for internatio...
Updates Guidance for Full Year 2017
MOUNTAIN VIEW, Calif., Aug. 3, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter and six months ended July 1, 2017.
Second Quarter Financial Results and Highlights
Total revenue of $10.0 million, a 16% year-over-year decline
Sold 69 Cyclo G6 systems and shipped approximately 7,100 G6 probes
Participation in the 7th World Glaucoma Congress in Helsinki, including a...
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.